Intravenous Administration of Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery

The aim of the study is to compare the effectiviness of biatrial pacing versus intravenous administration of metoprolol in the prevention of atrial fibrillation after cardiac surgery

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Biatrial Pacing Cardiovascular Diseases Heart Diseases Metoprolol Pathologic Processes Pathological Conditions, Signs and Symptoms

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Halonen Jari

Kuopio, FIN-70211, Finland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

elective CABG and aortic valve cardiac patients,
previous use of beta blocker

Exclusion criteria

Previous episodes of Atrial fibrillation or flutter,
II or II degree atrioventricular block, uncontrolled heart failure
Sick sinus syndrome

Treatment and study plan

metoprolol, biatrial pacing

Other

Prevention, atrial fibrillation, cardiac surgery, biatrial pacing, metoprolol

Primary outcomes

biatriac pacing

Time frame: 48 hours
Incidence of atrial fibrillation

Time frame: 48 hours

Sponsors and collaborators

Lead sponsor

Kuopio University Hospital

Other

Collaborators

Hospital Cordia, Kuopio, Finland
Oulu University Hospital

Registry information

Official study title

Intravenous Metoprolol Versus Biatrial Pacing in the Prevention of Atrial Fibrillation After Cardiac Surgery

Important dates

Study start: 2007
Primary completion: 2009
Study completion: 2009
First posted: Nov 3, 2008
Registry last updated: Mar 3, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed